SynthesisRheumatology international2017

Safety and efficacy of ocrelizumab in rheumatoid arthritis patients with an inadequate response to methotrexate or tumor necrosis factor inhibitors: a systematic review and meta-analysis.

Abdelrahman Ibrahim Abushouk et al.PubMed ↗Publisher ↗

No numbers read from the abstract.